These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1565 related items for PubMed ID: 30213667

  • 21. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis.
    de Oliveira da Silva B, Ramos LF, Moraes KCM.
    Cell Biol Int; 2017 Sep; 41(9):946-959. PubMed ID: 28498509
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis.
    Iwaisako K, Brenner DA, Kisseleva T.
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):65-8. PubMed ID: 22320919
    [Abstract] [Full Text] [Related]

  • 25. Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
    Khanam A, Saleeb PG, Kottilil S.
    Cells; 2021 May 04; 10(5):. PubMed ID: 34064375
    [Abstract] [Full Text] [Related]

  • 26. Reversal of liver cirrhosis: current evidence and expectations.
    Jung YK, Yim HJ.
    Korean J Intern Med; 2017 Mar 04; 32(2):213-228. PubMed ID: 28171717
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Hepatic fibrogenesis in response to chronic liver injury: novel insights on the role of cell-to-cell interaction and transition.
    Svegliati-Baroni G, De Minicis S, Marzioni M.
    Liver Int; 2008 Sep 04; 28(8):1052-64. PubMed ID: 18783548
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis.
    Baghaei K, Mazhari S, Tokhanbigli S, Parsamanesh G, Alavifard H, Schaafsma D, Ghavami S.
    Drug Discov Today; 2022 Apr 04; 27(4):1044-1061. PubMed ID: 34952225
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Hepatic stellate cells and extracellular matrix in hepatocellular carcinoma: more complicated than ever.
    Carloni V, Luong TV, Rombouts K.
    Liver Int; 2014 Jul 04; 34(6):834-43. PubMed ID: 24397349
    [Abstract] [Full Text] [Related]

  • 33. Metabolic Reprogramming of Liver Fibrosis.
    Delgado ME, Cárdenas BI, Farran N, Fernandez M.
    Cells; 2021 Dec 20; 10(12):. PubMed ID: 34944111
    [Abstract] [Full Text] [Related]

  • 34. Liver fibrosis - mouse models and relevance in human liver diseases.
    Mederacke I.
    Z Gastroenterol; 2013 Jan 20; 51(1):55-62. PubMed ID: 23315652
    [Abstract] [Full Text] [Related]

  • 35. Liver fibrosis.
    Aydın MM, Akçalı KC.
    Turk J Gastroenterol; 2018 Jan 20; 29(1):14-21. PubMed ID: 29391303
    [Abstract] [Full Text] [Related]

  • 36. Role of oxidative stress and molecular changes in liver fibrosis: a review.
    Sánchez-Valle V, Chávez-Tapia NC, Uribe M, Méndez-Sánchez N.
    Curr Med Chem; 2012 Jan 20; 19(28):4850-60. PubMed ID: 22709007
    [Abstract] [Full Text] [Related]

  • 37. Liver fibrosis: Direct antifibrotic agents and targeted therapies.
    Schuppan D, Ashfaq-Khan M, Yang AT, Kim YO.
    Matrix Biol; 2018 Aug 20; 68-69():435-451. PubMed ID: 29656147
    [Abstract] [Full Text] [Related]

  • 38. Placental growth factor silencing ameliorates liver fibrosis and angiogenesis and inhibits activation of hepatic stellate cells in a murine model of chronic liver disease.
    Li X, Yao QY, Liu HC, Jin QW, Xu BL, Zhang SC, Tu CT.
    J Cell Mol Med; 2017 Oct 20; 21(10):2370-2385. PubMed ID: 28378526
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 79.